C21 · Pharmaceuticals · United States
Pharmaceutical manufacturing facility capital investment
United States: 750 million USD in as of 20 Aug 2026.
- Irregular Release cadence
- 1 Record · 1 region · 2026
Verified 15 Sep 2026 · 1 publisher
The figure
One published observation so far. A chart follows as soon as a second period is published.
Pharmaceutical manufacturing facility capital investment
United States, as of 20 Aug 2026
Every record
1 record · 1 region · 2026. Each period links to its record: the value, its source evidence and original document.
| Period | Value | Source | Type |
|---|---|---|---|
| United States 1 record | |||
| as of 20 Aug 2026 | 750 million USD | Roche · 20 Aug 2026 | forecast |
Download this data
Every file carries its provenance: the CSV has a source column per row, and the chart images print the publisher, the licence and this page's address under the drawing. Source: Roche. Licence: CC BY 4.0.
Use and publication rights
- View, cite and link: free
Quote any number, cite this page or a single record, and link to it anywhere.
- Copy, chart and republish: free with attribution
The data is published under CC BY 4.0, commercial use included. Credit StatOrigin and the original publisher (Roche); the chart files already carry that line.
- The source documents: the publisher's terms
Figures are facts read from the publishers' own documents. The documents themselves, their text and design, stay under each publisher's terms; follow the source links for those.
How this measure is built
- Definition
- Total planned capital expenditure and investment in pharmaceutical manufacturing and fill-finish facilities.
- Measure
- One slice of Capital investment ( form: level, segment: manufacturing facilities ) . Total monetary funds invested in capital assets, facilities, or infrastructure. Region and period are columns on every record, not slices.
- Limitations
- 1 figure is a projection, drawn dashed and labelled in the table. Values are shown as published; StatOrigin does not revise, fill gaps or convert currencies.
- Verification
- Each value, unit, period and place was checked against its source evidence before publication. See the methodology and the corrections process.
Sources · 1 document
| Document | Publisher | Published | Data points |
|---|---|---|---|
| Roche’s US subsidiary Genentech announces manufacturing expansion in the United States | Roche | 20 Aug 2026 | 1 |
Other slices of capital investment
- Renewable energy investment 3 renewable energy
- Upstream oil and gas capital expenditure growth 3 upstream
- Energy transition investment 2 energy transition
- Renewable energy investment growth rate 2 renewable energy
- Capital expenditure on advanced-process semiconductor equipment 1 advanced node equipment
- Clean energy investment 1 clean energy
- Clean energy investment share in emerging and developing economies excluding China 1 clean energy
- Critical minerals investment growth rate 1 critical minerals
- Energy transition investment growth rate 1 energy transition
- Grid and storage investment per dollar of renewable power investment 1 grid and storage
- Growth rate of energy transition investment 1 energy transition
- Hyperscale operator capital expenditure (quarterly) 1 hyperscale operators
Frequently asked questions
What is the latest pharmaceutical manufacturing facility capital investment?
United States: 750 million USD in as of 20 Aug 2026.
Where does this data come from?
From 1 document published by Roche. Every figure on this page links to its record, which preserves the original source evidence.
How often is it updated?
Irregularly: the publishers behind this measure do not release it on a fixed schedule. A new figure appears here once it is published and verified.
Can I use this data?
Yes. StatOrigin publishes it under CC BY 4.0: you may copy, chart and republish it, including commercially, with attribution to StatOrigin and to the original publisher.
Cite this page
Cite the page as a data set, or open any record to cite one figure: each record carries APA, MLA, Chicago and BibTeX forms that credit the original publisher.
StatOrigin. (2026). Pharmaceutical manufacturing facility capital investment [Data set]. Retrieved October 28, 2026, from https://statorigin.org/indicators/pharmaceutical-manufacturing-facility-capital-investment
"Pharmaceutical manufacturing facility capital investment." StatOrigin, 2026, https://statorigin.org/indicators/pharmaceutical-manufacturing-facility-capital-investment. Accessed 28 Oct. 2026.
StatOrigin. "Pharmaceutical manufacturing facility capital investment." Data set, 2026. Accessed October 28, 2026. https://statorigin.org/indicators/pharmaceutical-manufacturing-facility-capital-investment.
@misc{statorigin_pharmaceutical_manufacturing_facility_capital_investment_2026, title = {Pharmaceutical manufacturing facility capital investment}, author = {{StatOrigin}}, year = {2026}, url = {https://statorigin.org/indicators/pharmaceutical-manufacturing-facility-capital-investment}, note = {Data set. Accessed 2026-10-28} }